Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Apr 12:11:1039720.
doi: 10.3389/fpubh.2023.1039720. eCollection 2023.

Virtual reality in chemotherapy support for the treatment of physical functions, fear, and quality of life in pediatric cancer patients: A systematic review and meta-analysis

Oliver Czech  1 , Sebastian Rutkowski  2 , Aleksandra Kowaluk  1   3 , Paweł Kiper  4 , Iwona Malicka  1
Affiliations
Meta-Analysis

Virtual reality in chemotherapy support for the treatment of physical functions, fear, and quality of life in pediatric cancer patients: A systematic review and meta-analysis

Oliver Czech et al. Front Public Health. .

Abstract

Background: Appropriately selected complementary therapies, such as virtual reality (VR) and active video games (AVG), provide support to young patients during the process of cancer treatment. Therefore, this systematic review with meta-analysis aimed to analyze the effects of VR and AVG on fear, physical functions, and quality of life.

Methods: A systematic search was performed independently in Scopus, PubMed, Embase, Web of Science and Cochrane Library electronic databases for relevant randomized controlled and crossover studies. From a total of 5,963 records, 11 met the inclusion criteria. After full-text screening two publications were excluded, yet six studies were included in the quantitative analysis because three studies had a large discrepancy in their measured outcomes. For methodological quality assessments, the RoB2 software program was used, while RevMan 5.4.1 was used for statistical analysis and meta-analysis. Standard Mean Difference (SMD) outcome measures were used for the analysis. Statistical heterogeneity was assessed using the I2 statistic with a cut-off value of 50% considering intervention and outcome measures.

Results: Our systematic review includes six randomized controlled studies and three randomized crossover studies. The participants represented both sexes and were children and adolescents (<18 years old) with a diagnosis of cancer. The analysis of the results allows for a careful conclusion that VR has the potential to become an accessory tool in rehabilitation and oncologic treatment. All of the included studies noted a significant advantage of this intervention.

Conclusion: VR has the potential to be an effective and important tool in the oncologic treatment of children. VR immerses the patient, and as a result, produces a distraction that effectively reduces pain associated with standard oncologic care procedures in children. However, this systematic review and meta-analysis highlights the need for more research into the use of VR as support for pediatric oncologic care.

Systematic review registration: PROSPERO database (https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=319000), CRD42022319000.

Keywords: anxiety; chemotherapy; childhood cancer; fear; pain; pediatric patients; virtual reality.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flowchart for review process.
Figure 2
Figure 2
Risk of bias assessment of RCT studies.
Figure 3
Figure 3
Risk of bias assessment of crossover studies.
Figure 4
Figure 4
Funnel plot of comparison 1.
Figure 5
Figure 5
Funnel plot of comparison 2.
Figure 6
Figure 6
Funnel plot of comparison 3.
See this image and copyright information in PMC

References

    1. Smith MA, Seibel NL, Altekruse SF, Ries LA, Melbert DL, O'leary M, et al. . Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol. (2010) 28:2625–34. 10.1200/JCO.2009.27.0421 - DOI - PMC - PubMed
    1. Hubbard AK, Spector LG, Fortuna G, Marcotte EL, Poynter JN. Trends in international incidence of pediatric cancers in children under 5 years of age: 1988–2012. JNCI Cancer Spectr. (2019) 3:pkz007. 10.1093/jncics/pkz007 - DOI - PMC - PubMed
    1. Altun I, Sonkaya A. The most common side effects experienced by patients were receiving first cycle of chemotherapy. Iran J Public Health. (2018) 47:1218–9. - PMC - PubMed
    1. Graef DM, Crabtree VM, Srivastava DK Li C, Pritchard M, Hinds PS, et al. . Sleep and mood during hospitalization for high-dose chemotherapy and hematopoietic rescue in pediatric medulloblastoma. Psychooncology. (2018) 27:1847–53. 10.1002/pon.4737 - DOI - PMC - PubMed
    1. Hedstrom M, Haglund K, Skolin I, Von Essen L. Distressing events for children and adolescents with cancer: child, parent, and nurse perceptions. J Pediatr Oncol Nurs. (2003) 20:120–32. 10.1053/jpon.2003.76 - DOI - PubMed